Can albumin 5% (1000 mL) be given to a patient with septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Albumin 5% 1000 mL Be Given for Septic Shock?

Yes, albumin 5% can be given to patients with septic shock, but only as an adjunct to crystalloids when substantial amounts of crystalloids have already been administered—not as first-line therapy. Crystalloids remain the primary resuscitation fluid, and albumin should be reserved for rescue situations after large crystalloid volumes have been given 1.

Guideline-Based Approach

First-Line Resuscitation

  • Start with crystalloids (either balanced crystalloids or normal saline) as the initial fluid of choice for resuscitation 1
  • Administer at least 30 mL/kg of crystalloids as the initial fluid challenge
  • Continue crystalloid administration as long as hemodynamic factors improve

When to Consider Albumin

Add albumin 5% only when:

  • The patient requires "substantial amounts" of crystalloids (typically interpreted as ≥30 mL/kg or ongoing large volume requirements)
  • Hemodynamic instability persists despite adequate crystalloid resuscitation
  • This is a weak recommendation with low-to-moderate quality evidence 1

Volume Considerations for 1000 mL of 5% Albumin

The 1000 mL volume you're asking about is reasonable and commonly used:

  • FDA labeling supports albumin 5% for hypovolemic shock and sepsis-related hypoproteinemia 2
  • The 2024 International Collaboration guideline notes that albumin has not shown mortality benefit but is not harmful when used appropriately 3
  • Monitor closely for circulatory overload, as albumin 5% is iso-oncotic and expands plasma volume approximately 1:1 with the infused volume

Critical Evidence Nuances

Mortality Data

The most recent high-quality evidence shows:

  • No mortality benefit from albumin in septic shock across multiple systematic reviews 3, 4, 5
  • A 2026 German RCT (INCEPT-Albumin) found no difference in 90-day mortality (43.3% vs 45.9%, p=0.71) 6
  • Trial sequential analysis suggests we have reached futility—meaning further studies are unlikely to show benefit 5

Concentration Matters

  • 5% albumin is preferred over 25% albumin for septic shock resuscitation
  • Recent 2025 data suggests 25% albumin may increase risk of RRT or mortality (OR 1.43) in patients with renal impairment, while 5% showed no significant difference (OR 1.07) 7
  • The 2024 guideline emphasizes lack of proven benefit and higher cost compared to crystalloids 3

Important Caveats and Pitfalls

Do NOT Use Albumin If:

  • Pediatric patients with febrile illness: A large RCT (FEAST trial, N=3,141) showed increased mortality with albumin boluses in children with severe febrile illness (RR 1.45) 3
  • As first-line fluid: This violates all major guidelines
  • For chronic hypoalbuminemia alone: In chronic nephrosis or cirrhosis without shock, albumin is rapidly excreted and provides no benefit 2

Monitor For:

  • Circulatory overload: Administer no faster than 2 mL/min in hypoproteinemic patients to avoid pulmonary edema 2
  • Renal function: In patients with baseline kidney impairment (eGFR <45), early albumin may increase risk of RRT requirement 7
  • Fluid balance: The 2024 CLASSIC trial showed substantial practice variation, with albumin use ranging from 36-53% depending on fluid strategy 8

Practical Algorithm

  1. Initial resuscitation: Give 30 mL/kg crystalloids rapidly
  2. Reassess hemodynamics: If shock persists after initial crystalloid bolus
  3. Continue crystalloids: Give additional crystalloid boluses with hemodynamic monitoring
  4. Consider albumin 5%: Only after ≥30-60 mL/kg crystalloids given and shock persists
  5. Dose: 1000 mL (50 g) of 5% albumin is a reasonable rescue dose
  6. Rate: Can give faster in shock (unlike hypoproteinemia without shock)
  7. Reassess frequently: Continue only if hemodynamic improvement occurs

The bottom line: Albumin 5% 1000 mL can be given, but crystalloids must come first, and the evidence does not support expecting improved survival—only potential hemodynamic support as a rescue measure 3, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.